Accéder au contenu
Merck

Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed.

Radiation and environmental biophysics (2013-03-12)
Christoph Reiners, Rita Schneider
RÉSUMÉ

Thyroid cancer in children and adolescents has to be considered as the most severe health consequence of a nuclear reactor emergency with release of radioiodine into the atmosphere. High doses of potassium iodide are effective to block radioiodine thyroid uptake and to prevent development of thyroid cancer years later. However, there are controversies concerning thyroid cancer risk induced by radioiodine exposure in adults. Further, the interaction of nutritional supply of potassium iodide and radioiodine uptake as well as the interaction of radioiodine with certain drugs has not been addressed properly in existing guidelines and recommendations. How to proceed in case of repeated release of radioiodine is an open, very important question which came up again recently during the Fukushima accident. Lastly, the side effects of iodine thyroid blocking and alternatives of this procedure have not been addressed systematically up to now in guidelines and recommendations. These questions can be answered as follows: in adults, the risk to develop thyroid cancer is negligible. In countries, where nutritional iodine deficiency is still an issue, the risk to develop thyroid cancer after a nuclear reactor emergency has to be considered higher because the thyroid takes up more radioiodine as in the replete condition. Similarly, in patients suffering from thyrotoxicosis, hypothyroidism or endemic goitre not being adequately treated radioiodine uptake is higher than in healthy people. In case of repeated or continued radioiodine release, more than one dose of potassium iodide may be necessary and be taken up to 1 week. Repeated iodine thyroid blocking obviously is not harmful. Side effects of iodine thyroid blocking should not be overestimated; there is little evidence for adverse effects in adults. Newborns and babies, however, may be more sensitive to side effects. In the rare case of iodine hypersensitivity, potassium perchlorate may be applied as an alternative to iodine for thyroid blocking.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Iodure de potassium, ACS reagent, ≥99.0%
Sigma-Aldrich
Iodure de potassium, ReagentPlus®, 99%
Sigma-Aldrich
Iodure de potassium, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Iodure de potassium, puriss. p.a., reag. ISO, reag. Ph. Eur., ≥99.0%
Sigma-Aldrich
Gold etchant, standard
Sigma-Aldrich
Iodure de potassium, puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)
Sigma-Aldrich
Iodure de potassium, ≥99.99% trace metals basis
Sigma-Aldrich
Iodure de potassium, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
Iodure de potassium, suitable for plant cell culture
Sigma-Aldrich
Iodure de potassium, AnhydroBeads, −10 mesh, 99.998% trace metals basis
Sigma-Aldrich
Iodure de potassium, puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)
Sigma-Aldrich
Iodure de potassium, BioXtra, ≥99.0%
Sigma-Aldrich
Iodure de potassium, tested according to Ph. Eur.